A-549	Lung adenocarcinoma
BxPC-3	Pancreatic ductal adenocarcinoma
COLO 205	Colon adenocarcinoma
DLD-1	Colon adenocarcinoma
DU145	Prostate carcinoma
GI50	Half-maximal inhibition of cell proliferation
GLOBOCAN	Global Cancer, Incidence, Mortality and Prevalence
HCC-S102	Hepatocellular carcinoma
HCT-116	Colon carcinoma
HeLa	Human papillomavirus-related endocervical adenocarcinoma
HepG2	Hepatoblastoma
HPLC	High performance liquid chromatography
HT-29	Colon adenocarcinoma
IC50	Half-maximal inhibitory concentration
IR	Infrared spectroscopy
KB	Human papillomavirus-related endocervical adenocarcinoma
MCF-7	Michigan Cancer Foundation-7 (breast cancer)
MDA-MB-231	MD Anderson-Metastatic Breast-231 (triple-negative breast cancer)
MS	Mass spectrometry
MTT	3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide
NCI-H187	Lung small-cell carcinoma
NMR	Nuclear magnetic resonance spectroscopy
PICO	Population, Intervention, Comparison and Outcome
PRISMA	Preferred Reporting Items for Systematic Reviews and Meta-Analyses
REMA	Resazurin microtiter assay
SAR	Structure–activity relationship
SGC-7901	Human papillomavirus-related endocervical adenocarcinoma
SMMC-7721	Human papillomavirus-related endocervical adenocarcinoma
SRB	Sulforhodamine B
T-47D	Breast cancer
TLC	Thin-layer chromatography
UV-Vis	Ultraviolet–visible spectroscopy
WHO	World Health Organization